Evaluating the role of neuronal nitric oxide synthase-containing striatal interneurons in methamphetamine-induced dopamine neurotoxicity

Neurotoxicity Research

Volumn 24, Issue 2, 2013, Pages 288-297

  Fricks Gleason, Ashley N ^a   Keefe, Kristen A ^b  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; Methamphetamine; Neurotoxicity; Nitric oxide synthase

Indexed keywords

DOPAMINE; METHAMPHETAMINE; NEUROKININ 1 RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; RIBOSOME INACTIVATING PROTEIN; SAPORIN; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BRAIN TISSUE; CELL LOSS; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; ENZYME ACTIVATION; ENZYME DEFICIENCY; INTERNEURON; MALE; NERVE CELL LESION; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALS; CORPUS STRIATUM; DOPAMINE AGENTS; DRUG EVALUATION, PRECLINICAL; INTERNEURONS; MALE; METHAMPHETAMINE; NITRIC OXIDE SYNTHASE TYPE I; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84879795159     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-013-9391-6     Document Type: Article

References (46)

1. Abekawa T, Ohmori T, Koyama T (1996) Effects of nitric oxide synthesis inhibition on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain. J Neural Transm 103(6):671-680
2. Bergstrom BP, Garris PA (2003) "Passive stabilization" of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat. J Neurochem 87(5):1224-1236
3. Bittner SE, Wagner GC, Aigner TG, Seiden LS (1981) Effects of a high-dose treatment of methamphetamine on caudate dopamine and anorexia in rats. Pharmacol Biochem Behav 14(4):481-486
4. Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W Jr, Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268(3):1571-1580
5. Brown JM, Quinton MS, Yamamoto BK (2005) Methamphetamine-induced inhibition of mitochondrial complex II: roles of glutamate and peroxynitrite. J Neurochem 95(2):429-436. doi: 10.1111/j.1471-4159.2005.03379.x
6. Callaghan RC, Cunningham JK, Sajeev G, Kish SJ (2010) Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders. Mov Disord 25(14):2333-2339. doi: 10.1002/mds.23263
7. Callaghan RC, Cunningham JK, Sykes J, Kish SJ (2012) Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug Alcohol Depend 120(1-3):35-40. doi: 10.1016/j.drugalcdep.2011.06.013
8. Cass WA (2000) Attenuation and recovery of evoked overflow of striatal serotonin in rats treated with neurotoxic doses of methamphetamine. J Neurochem 74(3):1079-1085
9. Cass WA, Manning MW (1999) Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine. J Neurosci 19(17):7653-7660
10. Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH (1991) Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci U S A 88(17):7797-7801
11. Deng X, Cadet JL (1999) Methamphetamine administration causes overexpression of nNOS in the mouse striatum. Brain Res 851(1-2):254-257
12. Di Monte DA, Royland JE, Jakowec MW, Langston JW (1996) Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase. J Neurochem 67(6):2443-2450
13. Figueredo-Cardenas G, Morello M, Sancesario G, Bernardi G, Reiner A (1996) Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res 735(2):317-324 0006-8993(96)00801-3 [pii]
14. Friedman SD, Castaneda E, Hodge GK (1998) Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol Biochem Behav 61(1):35-44
15. Friend DM, Son JH, Keefe KA, Fricks-Gleason AN (2013) Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity. J Pharmacol Exp Ther 344(2):511-521. doi: 10.1124/jpet.112.199745
16. Fujiyama F, Masuko S (1996) Association of dopaminergic terminals and neurons releasing nitric oxide in the rat striatum: an electron microscopic study using NADPH-diaphorase histochemistry and tyrosine hydroxylase immunohistochemistry. Brain Res Bull 40(2):121-127
17. Gerfen CR (1991) Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res 556(1):165-170
18. Hotchkiss AJ, Morgan ME, Gibb JW (1979) The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci 25(16):1373-1378
19. Howard CD, Keefe KA, Garris PA, Daberkow DP (2011) Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum. J Neurochem 118(4):668-676. doi: 10.1111/j.1471-4159.2011.07342.x
20. Hwang O, Baker H, Gross S, Joh TH (1998) Localization of GTP cyclohydrolase in monoaminergic but not nitric oxide-producing cells. Synapse 28(2):140-153. doi: 10.1002/(SICI)1098-2396(199802)28:2<140:AID-SYN4>3.0. CO;2-B
21. Imam SZ, Crow JP, Newport GD, Islam F, Slikker W Jr, Ali SF (1999) Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst. Brain Res 837(1-2):15-21
22. Imam SZ, Newport GD, Itzhak Y, Cadet JL, Islam F, Slikker W Jr, Ali SF (2001) Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J Neurochem 76(3):745-749
23. Itzhak Y, Ali SF (1996) The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo. J Neurochem 67(4):1770-1773
24. Itzhak Y, Gandia C, Huang PL, Ali SF (1998) Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity. J Pharmacol Exp Ther 284(3):1040-1047
25. Itzhak Y, Martin JL, Ail SF (2000) nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice. NeuroReport 11(13):2943-2946
26. Itzhak Y, Anderson KL, Ali SF (2004) Differential response of nNOS knockout mice to MDMA ("ecstasy")- and methamphetamine-induced psychomotor sensitization and neurotoxicity. Ann N Y Acad Sci 1025:119-128. doi: 10.1196/annals.1316.015
27. Li JL, Wang D, Kaneko T, Shigemoto R, Nomura S, Mizuno N (2000) Relationship between neurokinin-1 receptor and substance P in the striatum: light and electron microscopic immunohistochemical study in the rat. J Comp Neurol 418(2):156-163. doi: 10.1002/(SICI)1096-9861(20000306)418:2<156:AID- CNE3>3.0.CO;2-Z
28. Li JL, Kaneko T, Mizuno N (2001) Colocalization of neuronal nitric oxide synthase and neurokinin-1 receptor in striatal interneurons in the rat. Neurosci Lett 310(2-3):109-112
29. Maxwell JC (2005) Emerging research on methamphetamine. Curr Opin Psychiatry 18(3):235-242. doi: 10.1097/01.yco.0000165592.52811.8400001504- 200505000-00004
30. McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA (1998) Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci 18(20):8417-8422
31. Paxinos G, Watson C (2005) The rat brain in stereotaxic coordinates, 5th edn. Elselvier Academic, Burlington
32. Rushlow W, Flumerfelt BA, Naus CC (1995) Colocalization of somatostatin, neuropeptide Y, and NADPH-diaphorase in the caudate-putamen of the rat. J Comp Neurol 351(4):499-508. doi: 10.1002/cne.903510403
33. Saka E, Iadarola M, Fitzgerald DJ, Graybiel AM (2002) Local circuit neurons in the striatum regulate neural and behavioral responses to dopaminergic stimulation. Proc Natl Acad Sci U S A 99(13):9004-9009. doi: 10.1073/pnas.132212499132212499
34. Sammut S, Dec A, Mitchell D, Linardakis J, Ortiguela M, West AR (2006) Phasic dopaminergic transmission increases NO efflux in the rat dorsal striatum via a neuronal NOS and a dopamine D(1/5) receptor-dependent mechanism. Neuropsychopharmacology 31(3):493-505. doi: 10.1038/sj.npp.1300826
35. Sanchez V, Zeini M, Camarero J, O'Shea E, Bosca L, Green AR, Colado MI (2003) The nNOS inhibitor, AR-R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum. J Neurochem 85(2):515-524
36. Santos RM, Lourenco CF, Gerhardt GA, Cadenas E, Laranjinha J, Barbosa RM (2011) Evidence for a pathway that facilitates nitric oxide diffusion in the brain. Neurochem Int 59(1):90-96. doi: 10.1016/j.neuint.2011.05.016
37. Tata DA, Raudensky J, Yamamoto BK (2007) Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia. The European journal of neuroscience 26(3):739-748. doi: 10.1111/j.1460-9568.2007.05688.x
38. Vincent SR, Johansson O, Hokfelt T, Skirboll L, Elde RP, Terenius L, Kimmel J, Goldstein M (1983) NADPH-diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities. J Comp Neurol 217(3):252-263. doi: 10.1002/cne.902170303
39. Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler M, Gatley SJ, Miller E, Hitzemann R, Ding YS, Logan J (2001a) Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci 21(23):9414-9418
40. Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN (2001b) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158(3):377-382
41. Wiley RG, Lappi DA (1999) Targeting neurokinin-1 receptor-expressing neurons with [Sar9, Met(O2)11 substance P-saporin. Neurosci Lett 277(1):1-4
42. Woolverton WL, Ricaurte GA, Forno LS, Seiden LS (1989) Long-term effects of chronic methamphetamine administration in rhesus monkeys. Brain Res 486(1):73-78
43. Yu J, Cadet JL, Angulo JA (2002) Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain. J Neurochem 83(3):613-622
44. Zhu JP, Xu W, Angulo JA (2006a) Distinct mechanisms mediating methamphetamine-induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance p in the striatum of mice. Ann N Y Acad Sci 1074:135-148. doi: 10.1196/annals.1369.013
45. Zhu JP, Xu W, Angulo N, Angulo JA (2006b) Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration. Neurotoxicology 27(1):131-136. doi: 10.1016/j.neuro.2005. 05.014
46. Zhu J, Xu W, Wang J, Ali SF, Angulo JA (2009) The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice. J Neurochem 111(3):656-668. doi: 10.1111/j.1471-4159.2009. 06330.x